Peer Review reports
From: PCSK9 inhibitors and osteoporosis: mendelian randomization and meta-analysis
| Original Submission | ||
|---|---|---|
| 16 Sep 2023 | Submitted | Original manuscript |
| 19 Feb 2024 | Reviewed | Reviewer Report |
| 12 Jun 2024 | Reviewed | Reviewer Report |
| 19 Jun 2024 | Author responded | Author comments - Gang Rui |
| Resubmission - Version 2 | ||
| 19 Jun 2024 | Submitted | Manuscript version 2 |
| 21 Jun 2024 | Author responded | Author comments - Gang Rui |
| Resubmission - Version 3 | ||
| 21 Jun 2024 | Submitted | Manuscript version 3 |
| 25 Jun 2024 | Reviewed | Reviewer Report |
| 28 Jun 2024 | Reviewed | Reviewer Report |
| 1 Jul 2024 | Author responded | Author comments - Gang Rui |
| Resubmission - Version 4 | ||
| 1 Jul 2024 | Submitted | Manuscript version 4 |
| 8 Jul 2024 | Reviewed | Reviewer Report |
| Resubmission - Version 5 | ||
| Submitted | Manuscript version 5 | |
| Publishing | ||
| 8 Jul 2024 | Editorially accepted | |
| 16 Jul 2024 | Article published | 10.1186/s12891-024-07674-w |
You can find further information about peer review here.